학술논문
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance
Document Type
Article
Author
García-Marco, J.A.; Jiménez, J.L.; Recasens, V.; Zarzoso, M.F.; Ferrer, S.; González-Barca, E.; De Marcos, N.S.; García-Vela, J.A.; Ramírez, M.J.; Parraga, F.J.P.; Yañez, L.; De La Serna Torroba, J.; Malo, M.D.G.; Ariznavarreta, G.D.; Persona, E.P.; Guinaldo, M.A.R.; De Paz Arias, R.; Llanos, E.B.; Jarque, I.; Del Carmen Fernandez Valle, M.; Tatay, A.C.; De Oteyza, J.P.; Martin, E.M.D.; Fernández, I.P.; Martinez, R.M.; Costa, M.A.A.; Champ, D.; Suarez, J.G.; Díaz, M.G.; Carbonell, F.
Source
In: Haematologica . (Haematologica, 2019, 104(11):2249-2257)
Subject
Language
English
ISSN
15928721
03906078
03906078